US5696093A - Method of treating nasal congestion using neuropeptide Y Y2 agonist peptides
- Google Patents US5696093A - Method of treating nasal congestion using neuropeptide Y …

Pharmaceutical compositions and methods are described comprising at least one Y2
receptor-binding peptide; such as peptide YY (PYY); Neuropeptide Y (NPY) or Pancreatic …

Pharmaceutical compositions and methods are described comprising at least one Y2
receptor-binding peptide, such as peptide YY (PYY), Neuropeptide Y (NPY) or Pancreatic …

Pharmaceutical compositions and methods are described comprising at least one Y2
receptor-binding peptide. Such as peptide YY (PYY), Neuropeptide Y (NPY) or Pancreatic …

Pharmaceutical compositions and methods are described comprising at least one Y2
receptor-binding peptide. Such as peptide YY (PYY), Neuropeptide Y (NPY) or Pancreatic …

1. Field of the Invention This invention relates to the use of Substituted amides which
Selectively bind to mammalian Neuropeptide recep tors. It further relates to the use of these …

2. Description of the Related Art Neuropeptide Y, a peptide first isolated in 1982, is widely
distributed in the central and peripheral neurons and is responsible for a multitude of …

Y (NPY) or PYY that are formed by combining these peptides or a portion of these peptides
with a template that promotes biologically active folds. Typically, templates con sist of …

The invention provides cDNA sequence and a genomic DNA sequence which encodes the
human neuropeptide YY 1 receptor. These DNA sequences can be used to express the NPY …

Neuropeptide Y (NPY) is a neurotransmitter in sympathetic nerve fibers in human nasal
mucosa. Like norepinephrine, NPY acts as a vasoconstrictor. An established method of …